Hotbed/Location

Found 529,957 articles

• Progenity Acquires Medimetrics Assets and Strengthens Global Leadership Position for Ingestible Device Technologies

  9/18/2019

  Progenity, Inc., a privately held biotechnology company, has acquired assets of ingestible device company Medimetrics GmbH.

• FUJIFILM SonoSite, Inc. Taps the Allen Institute for Artificial Intelligence (AI2) Incubator to Interpret Ultrasound Images with AI

  9/18/2019

  FUJIFILM SonoSite, Inc., specialists in developing cutting-edge, point-of-care ultrasound solutions, and the Allen Institute of Artificial Intelligence (AI2) Incubator, builder of AI-first startups, announced today a collaboration to interpret ultrasound images with AI, enabling new ultrasound applications and enhanced accuracy.

• Worldwide Clinical Trials Hires Aman Khera to Lead Global Regulatory Strategy

  9/18/2019

  Khera will lead regulatory strategy and development services for the company’s sponsor clients across multiple therapeutic indications, clinical development stages and Worldwide’s expanding global clinical trial footprint.

• Founder of Zero Mass Water Awarded $500,000 Lemelson-MIT Prize

  9/18/2019

  Cody Friesen Recognized for Commitment to Invention, Education and Mentorship

• Clene Nanomedicine, Inc. Announces Selection of CNM-Au8 for the Harvard Led HEALEY ALS Platform Trial, a Clinical Trial for Amyotrophic Lateral Sclerosis

  9/18/2019

  Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, announced today that the Sean M. Healey & AMG Center for ALS at Mass General has selected CNM-Au8 for inclusion in the first ever Platform Trial for the treatment of amyotrophic lateral sclerosis (ALS).

• Martha A. Brumfield, PhD, Named Arizona Bioscience Leader of the Year

  9/18/2019

  The Arizona Bioindustry Association (AZBio) today announced that Martha A. Brumfield, PhD, Special Advisor to the CEO and past President and CEO at the Critical Path Institute (C-Path), will be honored as the Jon W. McGarity Arizona Bioscience Leader of the Year at the 2019 AZBio Awards on October 2, 2019, at the Phoenix Convention Center.

• Velan Launches Consent Solicitation to Reconstitute the Progenics Board With Its Five Highly-Qualified, Independent Director Nominees

  9/18/2019

  Velan Capital, L.P. (together with the other members of its group, “Velan” or “we”), one of the largest stockholders of Progenics Pharmaceuticals, Inc. (“Progenics” or the “Company”)(NASDAQ:PGNX), comprised of successful specialty pharmaceutical operators and financial services experts, today announced that it has filed a preliminary consent statement with the SEC and delivered a written consent to the Company seeking to reconstitute the Progenics Board of Directors

• Biodesix Announces New Clinical Data Demonstrating VeriStrat Testing Predicts Survival in Advanced NSCLC and Immunotherapy

  9/18/2019

  Positive Results from Multiple Studies Support Clinical Utility of VeriStrat Testing

• GenomSys, the Swiss Startup Disrupting Genomics Information Handling, Closes a CHF 9.3 Million Series A Investment Round

  9/18/2019

  The company raised CHF 9.3 million in this financing, driven by the accelerating development progress of its MPEG-G-based solution for DNA data processing.

• Researchers Shed Light on Bladder Cancer Population Not Receiving Curative Intent Therapy

  9/18/2019

  Bladder cancer is the fifth most common cancer in industrialized countries, affecting roughly 2.7 million people worldwide. Muscle-invasive bladder cancer (MIBC), an aggressive and potentially lethal form of the disease, affects between 20 and 25 percent of patients diagnosed each year.

• Making Quality Performance Manageable: Three Strategies for Health Plans

  9/18/2019

  A survey of health plans revealed they used more than 500 provider quality measures with very little overlap between insurers or with the 1,700 measures used by national and regional programs such as NCQA HEDIS®, Medicare Stars, PQRS, MACRA / MIPS, FEP, DSRIP and bundled payments.

• ESGO and ENGAGe launch the first-ever World Gynecologic Oncology Awareness Day (World GO Day) on September 20th, 2019

  9/18/2019

  The European Society of Gynaecological Oncology (ESGO) and the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) will launch on Friday, Sep 20th, 2019 the first-ever World Gynecologic Oncology Day.

• Aural Analytics, Inc. Selected to Chair Voice Session at the 10th Annual CNS Summit

  9/18/2019

  Voice session will cover real-world data and evidence of use of vocal biomarkers in clinical trials and a primer on AI Panelists include representatives from AbbVie, Takeda and Boehringer Ingelheim

• Elizabeth Nelson Appointed to Berkeley Lights Board of Directors

  9/18/2019

   Today Berkeley Lights, Inc. (BLI), the company dedicated to finding the best cell for any application, announced the appointment of experienced executive, investor, and strategic advisor Elizabeth "Betsey" Nelson to the Berkeley Lights' board of directors.

• United Imaging Granted Top Honor at 2019 Frost & Sullivan Asia-Pacific Best Practices Awards

  9/18/2019

  United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, received the Asia-Pacific Medical Imaging Visionary Innovation Leadership Award at the Frost & Sullivan Asia-Pacific Best Practices Awards Banquet recently.

• Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference

  9/18/2019

  Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the company's Chief Executive Officer, Nadav Kidron, will  present and participate in one-on-one meetings at the 2019 Ladenburg Thalmann Healthcare Conference to be held on September 24, 2019 in New York, NY.

• Artist/Activist Domenic Esposito Places 800 lb Opioid Spoon Sculpture at Johnson & Johnson Headquarters to Shine a Light on Sinister Opioid Production and Distribution Practices

  9/18/2019

  With the recent verdict against Johnson & Johnson, whereby Judge Thad Balkman ordered the company to pay Oklahoma $572 Million, ruling that J& J is responsible for fueling Oklahoma's opioid crisis, this art-activism was designed to inform the public that J&J has played a much larger role in the nation's on-going opioid epidemic.

• NIH Awards Subtle Medical, Inc. $1.6 Million Grant to Improve Safety of MRI Exams By Reducing Gadolinium Dose Using AI

  9/18/2019

  Healthcare technology company receives NIH funding for low dose MRI exams

• FDA grants Fast Track Designation for SPI-1005 in the Treatment of Meniere's Disease

  9/18/2019

  Sound Pharmaceuticals is pleased to announce that the FDA's Division of Neurology Products has granted its request for Fast Track Designation (FTD) involving SPI-1005 in the treatment of Meniere's Disease (MD)

• Katalyst Technologies Heats Up the Kitchen to Support Families Fighting Cancer

  9/18/2019

  This summer, team members from Katalyst Technologies competed in Culinary Care's Corporate Cook-Off.